Literature DB >> 8271779

Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.

K Kato1, M Hillsgrove, L Weinhold, D A Gorelick, W D Darwin, E J Cone.   

Abstract

The accessibility of saliva for rapid, noninvasive sampling makes it an attractive biological fluid for detecting drug use. However, little is known about salivary excretion patterns of the major cocaine metabolites, benzoylecgonine (BE) and ecgonine methyl ester (EME). Additionally, there is a general lack of information on the effects of salivary collection conditions on cocaine excretion in saliva. This study documents the profile of cocaine and metabolites in human saliva under stimulated and nonstimulated saliva flow conditions. Saliva samples were obtained periodically from six healthy volunteers who were administered three, equally spaced, single intravenous doses of 25 mg of cocaine during a 6-h test session. On different days, whole saliva was obtained either under nonstimulated or stimulated (sour candy) conditions. The samples were analyzed for cocaine and metabolites by GC/MS. Cocaine, BE, and EME were detected and quantitated in the saliva of all subjects. Cocaine was the predominant analyte identified in all samples. Nonstimulated saliva contained substantially more drug than stimulated samples. The ratio of the area under the curve (AUC) of cocaine in nonstimulated saliva to that of stimulated saliva was variable and ranged from 3.0 to 9.5. The AUC ratios of BE and EME were similar to those observed for cocaine. The lowering of cocaine concentration in saliva in the stimulated flow condition was likely due to an increase in saliva pH associated with increased saliva flow rate; it is known that an increase in saliva pH retards cocaine partitioning into this biological fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8271779     DOI: 10.1093/jat/17.6.338

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  8 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

Review 2.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

3.  Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

Authors:  Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

4.  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2016-01-22       Impact factor: 2.395

5.  Drug testing in oral fluid.

Authors:  Olaf H Drummer
Journal:  Clin Biochem Rev       Date:  2006-08

6.  Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.

Authors:  Riet Dams; Robin E Choo; Willy E Lambert; Hendree Jones; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2006-09-27       Impact factor: 4.492

7.  Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.

Authors:  Teresa R Gray; Riet Dams; Robin E Choo; Hendree E Jones; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2010-07-27       Impact factor: 2.395

Review 8.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.